Milestone Scientific Inc. [AMEX: MLSS] closed the trading session at $2.04 on 10/13/20. The day’s price range saw the stock hit a low of $1.66, while the highest price level was $2.17. The company report on October 13, 2020 that Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System and CathCheck™.
Agreement provides Premier’s 4,100 hospitals and 200,000 provider members with preferred access to CompuFlo® Epidural System and CathCheck™.
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has been awarded a group purchasing agreement for the CompuFlo® Epidural System and CathCheck™ with Premier. Effective November 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the CompuFlo® Epidural System and CathCheck™.
The stocks have a year to date performance of 46.76 percent and weekly performance of 27.50 percent. The stock has been moved at 48.91 percent over the last six months. The stock has performed 28.30 percent around the most recent 30 days and changed -3.32 percent over the most recent 3-months.
If compared to the average trading volume of 260.58K shares, MLSS reached to a volume of 2322501 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Milestone Scientific Inc. [MLSS]:
Northland Capital have made an estimate for Milestone Scientific Inc. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on September 16, 2020. While these analysts kept the previous recommendation, Maxim Group dropped their target price from $3 to $1.50. The new note on the price target was released on November 16, 2018, representing the official price target for Milestone Scientific Inc. stock. Previously, the target price had yet another drop from $5 to $4, while Maxim Group kept a Buy rating on MLSS stock.
The Average True Range (ATR) for Milestone Scientific Inc. is set at 0.17, with the Price to Sales ratio for MLSS stock in the period of the last 12 months amounting to 21.55. The Price to Book ratio for the last quarter was 6.80, with the Price to Cash per share for the same quarter was set at 0.25.
MLSS stock trade performance evaluation
Milestone Scientific Inc. [MLSS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 27.50. With this latest performance, MLSS shares gained by 28.30% in over the last four-week period, additionally plugging by 48.91% over the last 6 months – not to mention a rise of 88.89% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MLSS stock in for the last two-week period is set at 66.39, with the RSI for the last a single of trading hit 73.63, and the three-weeks RSI is set at 62.06 for Milestone Scientific Inc. [MLSS]. The present Moving Average for the last 50 days of trading for this stock 1.62, while it was recorded at 1.83 for the last single week of trading, and 1.79 for the last 200 days.
Milestone Scientific Inc. [MLSS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Milestone Scientific Inc. [MLSS] shares currently have an operating margin of -47.75 and a Gross Margin at +68.28. Milestone Scientific Inc.’s Net Margin is presently recorded at -89.85.
Return on Total Capital for MLSS is now -252.08, given the latest momentum, and Return on Invested Capital for the company is -465.11. Return on Equity for this stock declined to -465.11, with Return on Assets sitting at -116.14. When it comes to the capital structure of this company, Milestone Scientific Inc. [MLSS] has a Total Debt to Total Equity ratio set at 0.94. Additionally, MLSS Total Debt to Total Capital is recorded at 0.93, with Total Debt to Total Assets ending up at 0.24.
Reflecting on the efficiency of the workforce at the company, Milestone Scientific Inc. [MLSS] managed to generate an average of -$470,273 per employee. Receivables Turnover for the company is 3.25 with a Total Asset Turnover recorded at a value of 1.29.Milestone Scientific Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.90.
Earnings per share (EPS) analysis for Milestone Scientific Inc. [MLSS] stock
With the latest financial reports released by the company, Milestone Scientific Inc. posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.01/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -500.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MLSS.
Milestone Scientific Inc. [MLSS]: Insider Ownership positions
There are presently around $13 million, or 10.00% of MLSS stock, in the hands of institutional investors. The top three institutional holders of MLSS stocks are: VANGUARD GROUP INC with ownership of 1,859,310, which is approximately 113.958% of the company’s market cap and around 9.80% of the total institutional ownership; BLACKROCK INC., holding 1,816,827 shares of the stock with an approximate value of $3.71 million in MLSS stocks shares; and NORTHERN TRUST CORP, currently with $0.81 million in MLSS stock with ownership of nearly 395.946% of the company’s market capitalization.
Positions in Milestone Scientific Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 34 institutional holders increased their position in Milestone Scientific Inc. [AMEX:MLSS] by around 4,894,764 shares. Additionally, 6 investors decreased positions by around 875,967 shares, while 6 investors held positions by with 735,949 shares. The mentioned changes placed institutional holdings at 6,506,680 shares, according to the latest SEC report filing. MLSS stock had 26 new institutional investments in for a total of 1,434,455 shares, while 2 institutional investors sold positions of 782,471 shares during the same period.